MX2009008754A - Anticuerpos novedosos contra igf-1r. - Google Patents

Anticuerpos novedosos contra igf-1r.

Info

Publication number
MX2009008754A
MX2009008754A MX2009008754A MX2009008754A MX2009008754A MX 2009008754 A MX2009008754 A MX 2009008754A MX 2009008754 A MX2009008754 A MX 2009008754A MX 2009008754 A MX2009008754 A MX 2009008754A MX 2009008754 A MX2009008754 A MX 2009008754A
Authority
MX
Mexico
Prior art keywords
antibodies against
novel antibodies
against igf
antibodies
antigen binding
Prior art date
Application number
MX2009008754A
Other languages
English (en)
Spanish (es)
Inventor
Paul Andrew Hamblin
Jonathan Henry Ellis
Alan Peter Lewis
Michael Neil Burden
Radha Shah
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0702888.9A external-priority patent/GB0702888D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MX2009008754A publication Critical patent/MX2009008754A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MX2009008754A 2007-02-14 2008-02-12 Anticuerpos novedosos contra igf-1r. MX2009008754A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0702888.9A GB0702888D0 (en) 2007-02-14 2007-02-14 Novel Antibodies
US95321007P 2007-08-01 2007-08-01
PCT/EP2008/051655 WO2008098917A2 (en) 2007-02-14 2008-02-12 Novel antibodies against igf-ir

Publications (1)

Publication Number Publication Date
MX2009008754A true MX2009008754A (es) 2009-11-02

Family

ID=42025950

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008754A MX2009008754A (es) 2007-02-14 2008-02-12 Anticuerpos novedosos contra igf-1r.

Country Status (5)

Country Link
JP (1) JP2010518140A (ru)
KR (1) KR20090114449A (ru)
EA (1) EA200900991A1 (ru)
MX (1) MX2009008754A (ru)
PE (1) PE20090107A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102933604B (zh) 2010-02-23 2016-04-06 赛诺菲 抗-α2整联蛋白抗体及其用途
TWI560199B (en) 2010-08-31 2016-12-01 Sanofi Sa Peptide or peptide complex binding to α2 integrin and methods and uses involving the same
KR20150031217A (ko) * 2011-12-15 2015-03-23 더 로얄 인스티튜션 포 디 어드밴스먼트 오브 러닝/맥길 유니버시티 가용성 igf 수용체 fc 융합 단백질 및 이의 용도
WO2017068185A1 (en) * 2015-10-23 2017-04-27 Apogenix Ag Single-chain gitr-receptor agonist proteins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1399483B1 (en) * 2001-01-05 2010-04-14 Pfizer Inc. Antibodies to insulin-like growth factor i receptor
US8034904B2 (en) * 2002-06-14 2011-10-11 Immunogen Inc. Anti-IGF-I receptor antibody
US7538195B2 (en) * 2002-06-14 2009-05-26 Immunogen Inc. Anti-IGF-I receptor antibody
US7638605B2 (en) * 2003-05-01 2009-12-29 ImClone, LLC Fully human antibodies directed against the human insulin-like growth factor-1 receptor
WO2005058967A2 (en) * 2003-12-16 2005-06-30 Pierre Fabre Medicament Novel anti-insulin/igf-i hybrid receptor or anti-insulin/igf-i hybrid receptor and igf-ir antibodies and uses thereof
FR2873699B1 (fr) * 2004-07-29 2009-08-21 Pierre Fabre Medicament Sa Nouveaux anticorps anti igf ir rt leurs utilisations
WO2007000328A1 (en) * 2005-06-27 2007-01-04 Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa Antibodies that bind to an epitope on insulin-like growth factor 1 receptor and uses thereof
FR2888850B1 (fr) * 2005-07-22 2013-01-11 Pf Medicament Nouveaux anticorps anti-igf-ir et leurs applications

Also Published As

Publication number Publication date
JP2010518140A (ja) 2010-05-27
EA200900991A1 (ru) 2010-02-26
PE20090107A1 (es) 2009-03-20
KR20090114449A (ko) 2009-11-03

Similar Documents

Publication Publication Date Title
WO2008098917A3 (en) Novel antibodies against igf-ir
MX2010001237A (es) Nuevos anticuerpos.
WO2009052400A8 (en) Antibodies that bind to mammalian ngal and uses thereof
WO2010136311A3 (en) Compositions and methods for antibodies targeting complement protein c3b
PH12015501848A1 (en) Binding agents
NZ597023A (en) Monoclonal antibodies that bind to hGM-CSF and medical compositions comprising same
WO2006113546A3 (en) Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
UA92505C2 (ru) Композиции на основе антитела против cd3
MY174493A (en) Binding agents
WO2007116360A3 (en) Antibodies that bind human protein tyrosine phosphatase beta (hptpbeta) and uses thereof
AU2009260320A8 (en) Antibodies to IL-6 and their uses
UA106070C2 (ru) Антитело, которое специфически связывается с egfr и her3
MY194997A (en) Anti-ccr7 antibody drug conjugates
NZ592432A (en) Antibodies that specifically block the biological activity of a tumor antigen Kidney associated antigen 1 (KAAG1)
WO2012027721A3 (en) Antibodies to matrix metalloproteinase 9
TW200510459A (en) RG1 antibodies and uses thereof
MX2010006767A (es) Anticuerpos de virus de hepatitis c.
MX2009009926A (es) Anticuerpo tumor-especifico humano monoclonal.
MX2009004167A (es) Anticuerpos que enlazan epitopos cxcr7.
MX2022000325A (es) Anticuerpos dirigidos contra dll3 y usos de los mismos.
AU2018338322A1 (en) A33 antibody compositions and methods of using the same in radioimmunotherapy
NZ629553A (en) Anti-big-endothelin-1 (big-et-1) antibodies and uses thereof
UA99602C2 (ru) Антитело, специфически связывающееся с jam-a, способное ингибировать пролиферацию опухолевых клеток
WO2008151819A3 (en) Treatment of tumors using specific anti-l1 antibody
MX2009008754A (es) Anticuerpos novedosos contra igf-1r.